Suche nach dem Prostatakarzinom — Verbessert die Kombination von DRE, TRUS und PSA die Effizienz des Screenings?

  • W. J. Kirkels
  • F. H. Schröder
Conference paper

Zusammenfassung

Das Prostatakarzinom (PK) ist eine häufige Erkrankung bei Männern jenseits des 50. Lj. und liegt in den meisten Ländern an der zweiten Stelle der Krebstodesfälle beim Mann nach dem Lungenkarzinom. In der Europäischen Gemeinschaft beträgt die Krebstodesrate des Prostatakarzinoms ca. 9% (Moller-Jensen et al. 1990). Dabei ist die Inzidenz und Mortalität des PK in den meisten westlichen Ländern im Ansteigen begriffen. Dies ist teilweise durch die erhöhte Lebenserwartung bedingt, jedoch dadurch allein nicht zu erklären.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Babaian RJ, Mettlin C, Krane R, Murphy GP, Lee F, Drago JR, Chesley A, and the investigators of the American Cancer Society National Prostate Cancer Detection Project (in press). The relation of prostate specific antigen to digital rectal examination and transrectal ultrasonography. CancerGoogle Scholar
  2. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH (1992) The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147:817–821PubMedGoogle Scholar
  3. Bentvelsen FM, Schröder FH. Modalities available for screening for prostate cancer. Eur J Cancer, in pressGoogle Scholar
  4. Brawer MK, Lange PH (1989) PSA in the screening, staging and follow-up of early stage prostate cancer: a review of recent developments. World J Urol 7:7–11CrossRefGoogle Scholar
  5. Catalona WJ, Smith DS, Ratliff TL (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl J Med 324:1156–1161PubMedCrossRefGoogle Scholar
  6. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, Walsh PC (1987) Prostate specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. Clin Chem 33:1916–1920PubMedGoogle Scholar
  7. Chodak GW, Keller P, Schoenberg HW (1989) Assessment for screening for prostate cancer using the digital rectal examination. J Urol 141:1136–1138PubMedGoogle Scholar
  8. Cooner WH, Mosley BR, Rutherford CL et al. (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146–1154PubMedGoogle Scholar
  9. Faul P (1982) Experience with the German annual preventive check-up examination. In: Jacobi GH, Hohenfellner R (eds) Prostate cancer. Williams & Wilkins, Baltimore, pp 57–70Google Scholar
  10. Franks LM (1954) Latent carcinoma of the prostate. J Path Bact 68:603–616PubMedCrossRefGoogle Scholar
  11. Lee F, Torp-Pedersen ST, Littrup PJ et al. (1989) Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination and prostate specific antigen. Radiology 170:29–32PubMedGoogle Scholar
  12. Mettlin C, Lee F, Drago J, Murphy GP and the Investigators of the American Cancer Society National Prostate cancer Detection Project (1991) Findings on the detection of early prostate in 2425 men. Cancer 67:2949–2958PubMedCrossRefGoogle Scholar
  13. Moller-Jensen, Estève J, Møller H, Renard H (1990) Cancer in the European Community and its member states. Eur J Cancer 26:1167–1256CrossRefGoogle Scholar
  14. Mueller EJ, Crain TW, Thompson IM, Rodriguez FR (1988) An evaluation of serial digital rectal examinations in screening for prostate cacer. J Urol 140:1445–1447PubMedGoogle Scholar
  15. Myrtle KF, Klimley PG, Ivor LP, Bruni JF (1986) Clinical utility of prostate specific antigen (PSA) in the management of prostate cancer. Adv Cancer Diagnostics. Hybritech, San DiegoGoogle Scholar
  16. Ragde H, Bagley CM, Aldape HC (1989) Screening for prostatic cancer with high resolution ultrasound. J Endourol 3:115–123CrossRefGoogle Scholar
  17. Rifkin MD, Choi H (1988) Implications of small peripheral hypoechoic lesions in the endorectal US of the prostate. Radiology 166:619–622PubMedGoogle Scholar
  18. Selker HP (1986) Letters to the editor. N Engl J Med 314:714–715CrossRefGoogle Scholar
  19. Sheldon CA, Williams RD, Fraley EE (1980) Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 124:626–631PubMedGoogle Scholar
  20. Sidall JK, Cooper EH, Newling DWW, Robinson MRG, Whelan P (1986) An evaluation of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate. Eur Urol 12:123–130Google Scholar
  21. Terris MK, McNeal JE, Stamey TA (1992) Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 147:855–857PubMedGoogle Scholar
  22. Vallancien G, Prapotnich D, Sibert L, Lugagne PM, Veillon B, Brisset JM, Andre-Bougaran J (1989) Comparison of the efficacy of digital rectal examination and transrectal ultrasonography in the diagnosis of prostatic cancer. Eur Urol 16:321–324PubMedGoogle Scholar
  23. Waaler G, Ludvigsen TC, Runden TO, Stenehjem E, Ogreid P, Schei OM (1988) Digital rectal examination to screen for prostatic cancer. Eur Urol 15:34–36PubMedGoogle Scholar
  24. Watanabe H (1988) Screening for prostatic cancer in Japan. EORTC monograph 5: Progress and controversies in oncological urology II. Liss, New York, pp 99–110Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • W. J. Kirkels
  • F. H. Schröder

There are no affiliations available

Personalised recommendations